Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Rodman

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.
The British Journal of Cancer. Supplement|August 1, 1992
Disposition of antineoplastic agents in the very young childH L McLeod, M V Relling, W R Crom, et al.
Clinical Pharmacokinetics|March 1, 1987
Pharmacokinetics of anticancer drugs in childrenW R Crom, A M Glynn-Barnhart, J H Rodman, et al.
Journal of the National Cancer Institute|April 6, 1994
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumorsN M Marina, J H Rodman, D J Murry, et al.
Cancer Research|June 15, 1990
Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenograftsJ A Houghton, L G Williams, S S de Graaf, et al.
Clinical Pharmacology and Therapeutics|April 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Pharmaceutical Sciences|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Clinical Pharmacology|February 1, 1994
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pharmaceutical Research|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
The New England Journal of Medicine|August 12, 1993
A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell diseaseJ A Wilimas, P M Flynn, S Harris, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|January 27, 1998
Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.
The British Journal of Cancer. Supplement|August 1, 1992
Disposition of antineoplastic agents in the very young childH L McLeod, M V Relling, W R Crom, et al.
Clinical Pharmacokinetics|March 1, 1987
Pharmacokinetics of anticancer drugs in childrenW R Crom, A M Glynn-Barnhart, J H Rodman, et al.
Journal of the National Cancer Institute|April 6, 1994
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumorsN M Marina, J H Rodman, D J Murry, et al.
Cancer Research|June 15, 1990
Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenograftsJ A Houghton, L G Williams, S S de Graaf, et al.
Clinical Pharmacology and Therapeutics|April 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Pharmaceutical Sciences|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Clinical Pharmacology|February 1, 1994
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Pharmaceutical Research|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
The New England Journal of Medicine|August 12, 1993
A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell diseaseJ A Wilimas, P M Flynn, S Harris, et al.
Pageof 7